Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
Goal: Protect patients, satisfy legal and regulatory duties, preserve the company’s long‑term credibility, and manage the short‑term market shock as responsibly as possible. Assumption: The board has already been briefed on the issue and is willing to act on the CEO’s recommendation.Read the full answer
You have a patient safety issue, not a PR issue. The 6 month regulatory reporting timeline is the formal process, not the ethical or legal obligation to act now. Waiting for more data while patients continue to be exposed is criminal negligence exposure, not risk mitigation.Read the full answer